These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1797 related articles for article (PubMed ID: 33734962)

  • 61. [Not Available].
    Béguelin A
    Rev Med Suisse; 2021 Jan; 17(723):234. PubMed ID: 33507668
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Choe PG; Kang CK; Suh HJ; Jung J; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Park WB; Oh MD
    Emerg Infect Dis; 2021 Jan; 27(1):327-9. PubMed ID: 33050983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company.
    Moroni-Zentgraf PC; Keller C; Mahmoudi M; Kallsen K; Eschenfelder CC; Sigmund R; Müller HW; Baum P; Boos B; Schneider M; Mundt E
    Curr Med Res Opin; 2021 Jun; 37(6):939-947. PubMed ID: 33836626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
    Hicks SM; Pohl K; Neeman T; McNamara HA; Parsons KM; He JS; Ali SA; Nazir S; Rowntree LC; Nguyen THO; Kedzierska K; Doolan DL; Vinuesa CG; Cook MC; Coatsworth N; Myles PS; Kurth F; Sander LE; Mann GJ; Gruen RL; George AJ; Gardiner EE; Cockburn IA;
    J Infect Dis; 2021 Jan; 223(1):10-14. PubMed ID: 33009908
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
    PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
    Korth J; Wilde B; Dolff S; Anastasiou OE; Krawczyk A; Jahn M; Cordes S; Ross B; Esser S; Lindemann M; Kribben A; Dittmer U; Witzke O; Herrmann A
    J Clin Virol; 2020 Jul; 128():104437. PubMed ID: 32434708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.
    Jia X; Gesualdo P; Geno Rasmussen C; Alkanani AA; He L; Dong F; Rewers MJ; Michels AW; Yu L
    Diabetes Technol Ther; 2021 Jul; 23(7):517-521. PubMed ID: 33544017
    [No Abstract]   [Full Text] [Related]  

  • 69. Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.
    Xiong L; Li Q; Cao X; Xiong H; Huang M; Yang F; Liu Q; Meng D; Zhou M; Wang G; Tong J; Chen T; Zhang Y; He X; Fan Y; Zhang Y; Tang L; Jin Y; Xia J; Hu Y
    BMC Med; 2021 Jul; 19(1):163. PubMed ID: 34256745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.
    Nakamura A; Sato R; Ando S; Oana N; Nozaki E; Endo H; Miyate Y; Soma J; Miyata G
    Fukushima J Med Sci; 2021 Apr; 67(1):27-32. PubMed ID: 33642419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A high-throughput multiplexed microfluidic device for COVID-19 serology assays.
    Rodriguez-Moncayo R; Cedillo-Alcantar DF; Guevara-Pantoja PE; Chavez-Pineda OG; Hernandez-Ortiz JA; Amador-Hernandez JU; Rojas-Velasco G; Sanchez-Muñoz F; Manzur-Sandoval D; Patino-Lopez LD; May-Arrioja DA; Posadas-Sanchez R; Vargas-Alarcon G; Garcia-Cordero JL
    Lab Chip; 2021 Jan; 21(1):93-104. PubMed ID: 33319882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.
    Dogan M; Kozhaya L; Placek L; Gunter C; Yigit M; Hardy R; Plassmeyer M; Coatney P; Lillard K; Bukhari Z; Kleinberg M; Hayes C; Arditi M; Klapper E; Merin N; Liang BT; Gupta R; Alpan O; Unutmaz D
    Commun Biol; 2021 Jan; 4(1):129. PubMed ID: 33514825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
    Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    Chen Y; Tong X; Wang J; Huang W; Yin S; Huang R; Yang H; Chen Y; Huang A; Liu Y; Chen Y; Yuan L; Yan X; Shen H; Wu C
    J Infect; 2020 Sep; 81(3):420-426. PubMed ID: 32504745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.
    Haizler-Cohen L; Davidov A; Blitz MJ; Fruhman G
    Am J Obstet Gynecol; 2021 Jan; 224(1):112-114. PubMed ID: 32971014
    [No Abstract]   [Full Text] [Related]  

  • 78. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.
    Nakamura A; Ando S; Endo H; Sato R
    J Med Virol; 2021 Jul; 93(7):4608-4611. PubMed ID: 33760273
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation.
    Kang S; Yang M; He S; Wang Y; Chen X; Chen YQ; Hong Z; Liu J; Jiang G; Chen Q; Zhou Z; Zhou Z; Huang Z; Huang X; He H; Zheng W; Liao HX; Xiao F; Shan H; Chen S
    Nat Commun; 2021 May; 12(1):2697. PubMed ID: 33976229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.